Delivery Order SPE2DB22D2214-SPE2DB24FS5MJ

Award Date 6/21/24
Potential Completion Date 6/24/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,267.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a completion date of March 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $2,302.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a performance period extending to July 25, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $33,116.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a completion date of March 4, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling...
This federal contract award, valued at $3,450.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, which is valued at $999,999,999 and runs through November 2026. The contract covers the procurement of medical commodities, including specialty medications, brand-name and...
This federal contract award, valued at $2,992.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a completion date of June 6, 2025. The contract is a firm fixed-price delivery order and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,106.12 firm fixed-price delivery order is for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM, a pharmaceutical product, with a completion date of October 15, 2024. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,307.10, is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,527.89, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at $999,999,999, is a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award is a delivery order with a firm fixed price of $7,114.96 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a performance period through June 30, 2025. AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a ceiling value of $12,477.09 and a completion date of March 25, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB24FS5MJ
    Delivery Order

This federal contract award, valued at $3,003.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the contract supports the DLA's mission of providing medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 5/17/25, 9:47 AM